Biallelic mutations in SZT2 cause a discernible clinical entity with epilepsy, developmental delay, macrocephaly and a dysmorphic corpus callosum
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Brain and Development
- Vol. 40 (2) , 134-139
Abstract
No abstract availableKeywords
Funding Information
- Japanese Agency for Medical Research and Development
This publication has 9 references indexed in Scilit:
- Novel biallelic SZT2 mutations in 3 cases of early‐onset epileptic encephalopathyClinical Genetics, 2017
- KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1Nature, 2017
- SZT2 dictates GATOR control of mTORC1 signallingNature, 2017
- Early‐life epileptic encephalopathy secondary to SZT2 pathogenic recessive variantsEpileptic Disorders, 2016
- Whole exome sequencing in patients with white matter abnormalitiesAnnals of Neurology, 2016
- An Amino Acid Deletion in SZT2 in a Family with Non-Syndromic Intellectual DisabilityPLOS ONE, 2013
- Biallelic SZT2 Mutations Cause Infantile Encephalopathy with Epilepsy and Dysmorphic Corpus CallosumThe American Journal of Human Genetics, 2013
- A novel giant peroxisomal superoxide dismutase motif-containing proteinFree Radical Biology and Medicine, 2010
- Szt2, a novel gene for seizure threshold in miceGenes, Brain and Behavior, 2009